Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Non-Current Liabilities (2023 - 2024)

BioScience Health Innovations has reported Total Non-Current Liabilities over the past 2 years, most recently at $10947.0 for Q3 2024.

  • Quarterly Total Non-Current Liabilities rose 36.29% to $10947.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $10947.0 through Sep 2024, up 36.29% year-over-year, with the annual reading at $13074.0 for FY2023, 280.61% up from the prior year.
  • Total Non-Current Liabilities was $10947.0 for Q3 2024 at BioScience Health Innovations, up from $9011.0 in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $15235.0 in Q1 2023 and troughed at $901.0 in Q2 2023.